Pharmainfo.net officially launched e-journal " Pharmaceutical Reviews " (ISSN 1918-5561 ).
Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers
New Data Suggest Initial Use of Abbott’s HUMIRA® (adalimumab) May Help Prevent Further Joint Damage For Up To Five Years
Abbott to Present at 17th Annual Credit Suisse Health Care Conference
Abbott's XIENCE V™ Drug Eluting Stent Wins Prestigious Chicago Innovation Award
Abbott’s HUMIRA® (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn’s Disease
Abbott Receives Complete Response Letter from FDA for Controlled-Release Hydrocodone with Acetaminophen
Abbott Reports Strong Sales and Earnings Growth in Third Quarter; Again Raises Full-Year Earnings Outlook
Abbott's XIENCE V™ Drug Eluting Stent Outperforms TAXUS® in Key Efficacy and Safety Endpoints Out to Two Years
Abbott Announces New $5 Billion Share Repurchase Program
New Data Shows Abbott's Bioabsorbable Drug Eluting Stent Is Absorbed Within Two Years – Leaving Behind Functioning Blood Vessels
